FCMT
TMO icon

Founders Capital Management (Texas)’s Thermo Fisher Scientific TMO Stock Holding History

Founders Capital Management (Texas)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$6.9K – 384
2023
Q4 		$6.9K Hold
13
– – 0.01% 312
2023
Q3 		$6.58K Buy
+13
New +$6.93K 0.01% 321

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Founders Capital Management (Texas)'s TMO Position: Q1 2024 in Review

Founders Capital Management (Texas) sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 13 shares — an estimated $6.9K sold.

Founders Capital Management (Texas) first reported a position in TMO in Q3 2023 and held it in 2 quarters. The position peaked at $6.9K in Q4 2023. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Founders Capital Management (Texas) reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 13 Thermo Fisher Scientific shares in Q1 2024, an estimated $6.9K.
  • Founders Capital Management (Texas) first reported a position in Thermo Fisher Scientific in Q3 2023 and held it in 2 quarters.
  • Founders Capital Management (Texas)'s Thermo Fisher Scientific position peaked at $6.9K in Q4 2023.
  • 2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2024, filed 10 Apr 2024.